Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: Protocol paper for a mixed methods study
Loading...
Date
Authors
Rapport, Francis
Smith, Andrea L.
Cust, Anne E.
Mann, Graham
Watts, Caroline G.
Gyorki, David E.
Henderson, Michael
Hong, Angela
Kelly, John
Long, Georgina V.
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ Publishing Group
Abstract
Introduction Sentinel lymph node biopsy (SLNB) is a
diagnostic procedure developed in the 1990s. It is currently
used to stage patients with primary cutaneous melanoma,
provide prognostic information and guide management.
The Australian Clinical Practice Guidelines state that SLNB
should be considered for patients with cutaneous melanoma
>1mm in thickness (or >0.8mm with high-risk pathology
features). Until recently, sentinel lymph node (SLN) status
was used to identify patients who might benefit from a
completion lymph node dissection, a procedure that is no
longer routinely recommended. SLN status is now also
being used to identify patients who might benefit from
systemic adjuvant therapies such as anti-programmed cell
death 1 (PD1) checkpoint inhibitor immunotherapy or BRAFdirected molecular targeted therapy, treatments that have
significantly improved relapse-free survival for patients with
resected stage III melanoma and improved overall survival of
patients with unresectable stage III and stage IV melanoma.
Australian and international data indicate that approximately
half of eligible patients receive an SLNB.
Methods and analysis This mixed-methods study
seeks to understand the structural, contextual and
cultural factors affecting implementation of the SLNB
guidelines. Data collection will include: (1) cross-sectional
questionnaires and semistructured interviews with general
practitioners and dermatologists; (2) semistructured
interviews with other healthcare professionals involved
in the diagnosis and early definitive care of melanoma
patients and key stakeholders including researchers,
representatives of professional colleges, training
organisations and consumer melanoma groups; and (3)
documentary analysis of documents from government,
health services and non-government organisations.
Descriptive analyses and multivariable regression models
will be used to examine factors related to SLNB practices
and attitudes. Qualitative data will be analysed using
thematic analysis.
Description
Keywords
Citation
Collections
Source
BMJ Open
Type
Book Title
Entity type
Access Statement
Open Access
License Rights
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license
Restricted until
Downloads
File
Description